Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.verified

603520.SS

Price:

$9.46

Market Cap:

$4.15B

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-03-09

Stock Exchange

SHH

Ticker

603520.SS

The PE Ratio as of December 2025 (TTM) for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) is -135.14

According to Zhejiang Starry Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -135.14. This represents a change of -85.43% compared to the average of -927.45 of the last 4 quarters.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Historical PE Ratio (quarterly & annually)

How has 603520.SS PE Ratio performed in the past?

The mean historical PE Ratio of Zhejiang Starry Pharmaceutical Co.,Ltd. over the last ten years is 26.70. The current -135.14 PE Ratio has changed -50708.42% with respect to the historical average. Over the past ten years (40 quarters), 603520.SS's PE Ratio was at its highest in in the September 2023 quarter at 327.55. The PE Ratio was at its lowest in in the September 2025 quarter at -3842.47.

Quarterly (TTM)
Annual

Average

26.70

Median

41.81

Minimum

-93.12

Maximum

108.31

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Zhejiang Starry Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 209.89%

Maximum Annual PE Ratio = 108.31

Minimum Annual Increase = -289.90%

Minimum Annual PE Ratio = -93.12

Quarterly (TTM)
Annual
YearPE RatioChange
2024-72.42-166.86%
2023108.31-216.31%
2022-93.12-289.90%
202149.04-25.51%
202065.8357.40%
201941.8228.35%
201832.59-22.04%
201741.80-40.68%
201670.46209.89%
201522.74-2.60%

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Average PE Ratio

How has 603520.SS PE Ratio performed in the past?

The current PE Ratio of Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-19.08

5-year avg

11.53

10-year avg

26.70

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) PE Ratio vs. Peers

How is 603520.SS’s PE Ratio compared to its peers?

Zhejiang Starry Pharmaceutical Co.,Ltd.’s PE Ratio is less than Zhuhai Rundu Pharmaceutical Co., Ltd. (-80.33), less than Wuhan Hiteck Biological Pharma Co.,Ltd (-19.76), less than Yabao Pharmaceutical Group Co., Ltd (20.83), less than Jinhe Biotechnology Co. Ltd. (36.43), less than Tibet Weixinkang Medicine Co., Ltd. (21.38), less than Harbin Medisan Pharmaceutical Co., Ltd. (-21.74), less than LanZhou Foci Pharmaceutical Co.,Ltd. (82.29), less than Beijing Beilu Pharmaceutical Co., Ltd (128.21), less than Tianjin Tianyao Pharmaceuticals Co., Ltd. (285.45), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (17.51),

Build a custom stock screener for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Starry Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Starry Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Zhejiang Starry Pharmaceutical Co.,Ltd.'s PE Ratio?

How is the PE Ratio calculated for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

What is the highest PE Ratio for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

What is the 3-year average PE Ratio for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

What is the 5-year average PE Ratio for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

How does the current PE Ratio for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) compare to its historical average?